Stock Track01-13
Abivax S.A. (ABVX) experienced a significant intraday surge of 5.08%, reflecting strong investor interest in the stock.
The price movement follows a report from Truist Financial, where analyst Gregory Renza maintained a Buy rating on Abivax SA Sponsored ADR. This positive endorsement likely contributed to the increased buying activity and the subsequent rise in the stock price.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
